Combinations of conventional disease-modifying antirheumatic drugs

Rheumatic Disease Clinics of North America

Volumn 27, Issue 2, 2001, Pages 415-426

  O'Dell, James R ^b  

^a NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; DRUG TOLERABILITY; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

EID: 0035018899     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-857X(05)70210-6     Document Type: Article

References (41)

1. M. Boers A.C. Verhoeven H.M. Markusse Randomized comparison of combined step down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis Lancet 350 1997 309 318
2. M. Calguneri S. Pay Z. Caliskaner Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis Clin Exp Rheumatol 17 1999 699 704
3. C. Egsmose B. Lung G. Borg Patients with rheumatoid arthritis benefit from early second-line therapy: 5-year follow-up of a prospective double-blind placebo-controlled study J Rheumatol 22 1995 2208 2213
4. M.J. Elliott R.N. Maini M. Reldmann Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor ? (eA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105 1110
5. D.T. Felson J.J. Anderson M. Boers American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 1995 727 735
6. J. Bathon R.W. Martin R.M. Fleischmann A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis N Engl J Med 343 2000 1586 1593
7. R.A. Greenwald S.A. Moak N.S. Ramamurthy Tetracyclines suppress matrix metalloproteinase activity in adjuvant arthritis and in combination with flurbiprofen ameliorate bone damage J Rheumatol 19 1992 927 938
8. R.A. Herman P. Veng-Pedersen J. Hoffman Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis patients J Pharm Sci 78 1989 165 171
9. The Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis Ann Rheum Dis 19 1960 331 337
10. The Joint Committee of the Medical Research Council and Nuffield Foundation on Clinical Trials of Cortisone, ACTH, and Other Therapeutic Measures in Chronic Rheumatic Diseases A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis Ann Rheum Dis 18 1959 173 187
11. Kirwan J.R. the Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group The effect of glucocorticoids on joint destruction in rheumatoid arthritis N Engl J Med 333 1995 142 146
12. M. Kloppenburg F.C. Breedveld J. Terwiel Minocycline in active rheumatoid arthritis Arthritis Rheum 37 1994 629 636
13. J.M. Kremer Combination therapy with biologic agents in rheumatoid arthritis: Perils and promise Arthritis Rheum 41 1998 1548 1551
14. J.M. Kremer J.R. Caldwell G.W. Cannon The combination of leflunomide and methotrexate in patients with active rheumatoid arthritis who are failing on methotrexate alone: A double-blind placebo controlled study Arthritis Rheum 43 2000 S224
15. R.N. Maini F.C. Breedveld J.R. Kalden Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis Arthritis Rheum 41 1998 1552 1563
16. T. Mikuls J. O'Dell The treatment of rheumatoid arthritis: Current trends in therapy Arthritis Rheum 42 1999 S79
17. L.W. Moreland S.W. Baumgartner M.H. Schiff Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein N Engl J Med 337 1997 141 147
18. T. Mottonen P. Hannonsen M. Leirasalo-Repo Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: A randomised trial Lancet 353 1999 1568 1573
19. M.H. Neva M.J. Kauppi H. Kautiainen Combination drug therapy retards the development of rheumatoid arthritis atlantoaxial subluxations Arthritis Rheum 43 2000 2397 2401
20. J. O'Dell Rheumatoid Arthritis Investigational Network (RAIN). Combination DMARD therapy for rheumatoid arthritis: Apparent universal acceptance [abstract] Arthritis Rheum 40 suppl 1997 S50
21. J. O'Dell G. Paulsen C. Haire Combination DMARD therapy with methotrexate (M)-sulfasalazine (S)-hydroxychloroquine (H) in rheumatoid arthritis (RA): Continued efficacy with minimal toxicity at 5 years Arthritis Rheum 41 suppl 1998 S132
22. J. O'Dell R. Leff G. Paulsen Methotrexate (M)-hydroxychloroquine(H)-sulfasalazine(S) versus M-H or M-S for rheumatoid arthritis (RA): Results of a double-blind study Arthritis Rheum 42 1999 S117
23. J.R. O'Dell C. Haire N. Erikson Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate J Rheumatol 23 suppl 44 1996 72 74
24. J.R. O'Dell B.S. Nepom C. Haire HLA-DRB1 typing in rheumatoid arthritis: Predicting response to specific treatments Ann Rheum Dis 57 1998 209 213
25. J.R. O'Dell C.E. Haire N. Erikson Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine, and hydroxychloroquine, or a combination of all three medications N Engl J Med 334 1996 1287 1291
26. J.R. O'Dell C.E. Haire W. Palmer Treatment of early rheumatoid arthritis with minocycline or placebo Arthritis Rheum 40 1997 842 848
27. J.R. O'Dell G. Paulsen C.E. Haire Treatment of early seropositive rheumatoid arthritis with minocycline: Four-year followup of a double-blind, placebo-controlled trial Arthritis Rheum 42 1999 1691 1695
28. H.E. Paulus M.J. Egger J.R. Ward Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo Arthritis Rheum 33 1990 477 484
29. R.S. Pinals A.T. Masi Larsen R.A. for the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for clinical remission in rheumatoid arthritis Arthritis Rheum 24 1981 1308 1315
30. T. Pincus S.B. Marcum L.F. Callahan Long-term drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone J Rheumatol 19 1992 1885 1894
31. J.S. Smolen J.R. Kalden B. Rozman A double-blind, randomized, phase III trial of leflunomide vs placebo vs sulfasalazine in rheumatoid arthritis [abstract] Arthritis Rheum 41 suppl 1998 S131
32. B.C. Tilley G.S. Alarcon S.P. Heyse Minocycline in rheumatoid arthritis Ann Intern Med 122 1995 81 89
33. E. Tsakonas A.A. Fitzgerald M.A. Fitzcharles Consequences of delayed therapy with second-line agents in rheumatoid arthritis: A 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study J Rheumatol 27 2000 623 629
34. P. Tugwell T. Pincus D. Yocum Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis N Engl J Med 333 1995 137 141
35. A. Weaver J. Caldwell N. Olsen Treatment of active rheumatoid arthritis with leflunomide compared to placebo or methotrexate [abstract] Arthritis Rheum 41 suppl 1998 S131
36. M.E. Weinblatt J.M. Kremer J.S. Coblyn Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis Arthritis Rheum 48 1999 1322 1328
37. M.E. Weinblatt J.M. Kremer A.D. Bankhurst A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate N Engl J Med 340 1999 253 259
38. K.R. Wilske L.A. Healey Remodeling the pyramid—a concept whose time has come J Rheumatol 16 1989 565 567
39. F. Wolfe The epidemiology of drug treatment failure in rheumatoid arthritis Baillieres Clin Rheumatol 9 1995 619 632
40. D.E. Yocum M. Stein T. Pincus Long-term safety of cyclosporin/Sandimmune(CsA/SIM) alone and in combination with methotrexate (MTX) in the treatment of active rheumatoid arthritis (RA): Analysis of open-label extension studies Arthritis Rheum 41 suppl 1998 S364
41. L.P. Yu G.N. Smith K. Brandt Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline Arthritis Rheum 35 1993 1150 1159